The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Ultra-Low-Dose Buprenorphine as a Time-Limited Treatment for Severe Suicidal Ideation: A Randomized Controlled Trial
Abstract
OBJECTIVE: Suicidal ideation and behavior currently have no quick-acting pharmacological treatments that are suitable for independent outpatient use. Suicidality is linked to mental pain, which is modulated by the separation distress system through endogenous opioids. The authors tested the efficacy and safety of very low dosages of sublingual buprenorphine as a time-limited treatment for severe suicidal ideation. METHOD: This was a multisite randomized double-blind placebo-controlled trial of ultra-low-dose sublingual buprenorphine as an adjunctive treatment. Severely suicidal patients without substance abuse were randomly assigned to receive either buprenorphine or placebo (in a 2:1 ratio), in addition to their ongoing individual treatments. The primary outcome measure was change in suicidal ideation, as assessed by the Beck Suicide Ideation Scale at the end of each of 4 weeks of treatment. RESULTS: Patients who received ultra-low-dose buprenorphine (initial dosage, 0.1 mg once or twice daily; mean final dosage=0.44 mg/day; N=40) had a greater reduction in Beck Suicide Ideation Scale scores than patients who received placebo (N=22), both after 2 weeks (mean difference -4.3, 95% CI=-8.5, -0.2) and after 4 weeks (mean difference=-7.1, 95% CI=-12.0, -2.3). Concurrent use of antidepressants and a diagnosis of borderline personality disorder did not affect the response to buprenorphine. No withdrawal symptoms were reported after treatment discontinuation at the end of the trial. CONCLUSIONS: The time-limited, short-term use of very low dosages of sublingual buprenorphine was associated with decreased suicidal ideation in severely suicidal patients without substance abuse. Further research is needed to establish the efficacy, safety, dosing, and appropriate patient populations for this experimental treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“that buprenorphine—a μ opioid partial agonist—is also effective on suicidal ideas,36”
From Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial (2022) · cites this paper as [36]
In the citing paper
“The kappa opioid receptor system may play a role in negative affect associated with suicidal ideation and may explain the possible antisuicidal effects of the kappa antagonist buprenorphine (139, 140).”
From A brain-centric model of suicidal behavior (2020) · cites this paper as [140]
In the citing paper
“probably through modulating emotional pain/psych-ache.”
From A brain-centric model of suicidal behavior (2020) · cites this paper as [140]
In the citing paper
“Compared with placebo, low-dose buprenorphine reduces suicidal ideation in 2 weeks in individuals who have never used opioids (140)”
From A brain-centric model of suicidal behavior (2020) · cites this paper as [140]
In the citing paper
“and may also reduce suicidal ideation (139, 140, 283, 285, 286).”
From A brain-centric model of suicidal behavior (2020) · cites this paper as [140]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Inhibitions, Symptoms and Anxiety
Freud, S. (1936) · The Psychoanalytic Quarterly · doi:10.1080/21674086.1936.11925284 · Cited by 1,764
Hawton, K., & van Heeringen, K. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60372-x · Cited by 1,671
The psychology of suicidal behaviour
O'Connor, R. C., & Nock, M. K. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70222-6 · Cited by 1,193 · cited 3×
“The relationship between suicidalityanddepressioniscomplex(1,2,5,6),andourfindings in this study appear to support the view that suicidal ideation and depression may be distinct, although related, phenomena, at least with respect to their response to pharmacotherapy.”
BackgroundEisenberger, N. I. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3231 · Cited by 1,016
Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis
Cipriani, A., Hawton, K., Stockton, S., & Geddes, J. R. (2013) · BMJ · doi:10.1136/bmj.f3646 · Cited by 920 · cited 1×
“Atypical antipsychotics (8, 9) and lithium (10) have been found to decrease suicidal ideation and/or suicidal behavior in specific patient populations.”
BackgroundThe archaeology of mind: neuroevolutionary origins of human emotions
(2013) · Choice Reviews Online · doi:10.5860/choice.50-3555 · Cited by 794
Self-citationCommentary: Suicide as Psychache
SHNEIDMAN, E. S. (1993) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199303000-00001 · Cited by 775
Acetaminophen Reduces Social Pain: Behavioral and Neural Evidence
DeWall, C. N., MacDonald, G., Webster, G. D., Masten, C. L., Baumeister, R. F., Powell, C., Combs, D., Schurtz, D. R., Stillman, T. F., Tice, D. M., et al. (2010) · Psychological Science · doi:10.1177/0956797610374741 · Cited by 486
A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
Lapidus, K. A. B., Levitch, C. F., Perez, A. M., Brallier, J. W., Parides, M. K., Soleimani, L., Feder, A., Iosifescu, D. V., Charney, D. S., & Murrough, J. W. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.03.026 · Cited by 480 · cited 1×
“Ketamine is effective as a quick-acting treatment for suicidal ideation and depression, but necessitates repeated administration under medical supervision (11, 12).”
Background(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.2.183 · Cited by 436
Research works printed but not linked: 3
- Bowlby J. Loss: Sadness and Depression (Attachment and Loss, vol 3; International Psycho-Analytical Library, No 109). London, Hogarth Press, 1980
- Beck AT, 1996, Manual for the Beck Depression Inventory–II
- Cull JG, 1988, Suicide Probability Scale Manual
Cited by
Turecki, G., Brent, D. A., Gunnell, D., O’Connor, R. C., Oquendo, M. A., Pirkis, J., & Stanley, B. H. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0121-0 · Cited by 1,074
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
Williams, N. R., Heifets, B. D., Blasey, C., Sudheimer, K., Pannu, J., Pankow, H., Hawkins, J., Birnbaum, J., Lyons, D. M., Rodriguez, C. I., et al. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18020138 · Cited by 519
Anhedonia is associated with suicidal ideation independently of depression: A meta-analysis
Ducasse, D., Loas, G., Dassa, D., Gramaglia, C., Zeppegno, P., Guillaume, S., Olié, E., & Courtet, P. (2018) · Depression and Anxiety · doi:10.1002/da.22709 · Cited by 269
A brain-centric model of suicidal behavior
Mann, J. J., & Rizk, M. M. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20081224 · Cited by 214
Psychological pain, depression, and suicide: Recent evidences and future directions
Conejero, I., Olié, E., Calati, R., Ducasse, D., & Courtet, P. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0893-z · Cited by 206
Metadata
- Authors
- Yovell, Y., Bar, G., Mashiah, M., Baruch, Y., Briskman, I., Asherov, J., Lotan, A., Rigbi, A., & Panksepp, J.
- Affiliations
- Wolfson Medical Center (IL)
- Venue
- American Journal of Psychiatry
- Published
- 2016-05-01
- Volume
- 173
- Issue
- 5
- Pages
- 491-498
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2202695658
- Cited by
- 311
- References
- 39
- Citations by year
- 2026: 11 · 2025: 24 · 2024: 19 · 2023: 14 · 2022: 24 · 2021: 59 · 2020: 36 · 2019: 28 · 2018: 49 · 2017: 22 · 2016: 22
- FWCI
- 39.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- buprenorphine, suicidal ideation, sublingual administration, time-limited therapy, endogenous opioids, separation distress, adjunctive pharmacotherapy, borderline personality disorder, antidepressants, suicide prevention
- MeSH terms
- Administration, Sublingual, Adult, Mental Disorders, Buprenorphine, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Narcotic Antagonists, Psychotropic Drugs, Time Factors, Treatment Outcome, Young Adult, Suicidal Ideation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ultra-Low-Dose Buprenorphine as a Time-Limited Treatment for Severe Suicidal Ideation: A Randomized Controlled Trial. https://app.cochat.ai/papers/10.1176/appi.ajp.2015.15040535
- The paper
- Yovell, Y., Bar, G., Mashiah, M., Baruch, Y., Briskman, I., Asherov, J., Lotan, A., Rigbi, A., & Panksepp, J. (2016). Ultra-Low-Dose Buprenorphine as a Time-Limited Treatment for Severe Suicidal Ideation: A Randomized Controlled Trial. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2015.15040535
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.